je.st
news
Tag: genetics
Genetics reveals where emperor penguins survived the last ice age
2015-03-01 07:33:00| Climate Ark Climate Change & Global Warming Newsfeed
ScienceDaily: A study of how climate change has affected emperor penguins over the last 30,000 years found that only three populations may have survived during the last ice age, and that the Ross Sea in Antarctica was likely the refuge for one of these populations. The Ross Sea is likely to have been a shelter for emperor penguins for thousands of years during the last ice age, when much of the rest of Antarctica was uninhabitable due to the amount of ice. The findings, published today in the journal Global...
Tags: age
ice
reveals
genetics
Richard Myers of Hudsonalpha talks genetics and genomics
2015-02-15 05:42:27| Biotech - Topix.net
Hudsonalpha is leading the study of human genetics and genomics. Rick Myers is the President of the Institute for Biotechnology and describes his company's mission as, "We do a lot of things there, but our basic mission is three-fold.
Tags: richard
talks
genetics
myers
Seattle Genetics' pipeline investments lead to $27M Q4 loss, stock up slightly
2015-02-11 03:12:04| Biotech - Topix.net
Bothell-based biotech Seattle Genetics , which develops cancer treatments, posted a $27 million loss on revenue of $74 million in its fourth quarter earnings today. While the company's overall sales of $74 million in the fourth quarter increased from $67 million in fourth quarter 2013, its losses also increased to $27 million from $15.7 million during the same quarter a year ago.
BEEF Seedstock 100 shows how genetics providers help their customers compete
2015-01-29 19:09:00| Beef
Seedstock producers are capturing more objective data than ever before in the name of building genetics with increasing levels of predictability. Cattle Economics read more
Tags: their
shows
customers
providers
Seattle Genetics and Takeda Announce Four-Year Survival Data from...
2014-12-08 13:13:49| Biotech - Topix.net
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited has announced four-year overall survival data from the ADCETRIS pivotal Phase 2 clinical trial in relapsed or refractory systemic anaplastic large cell lymphoma . ADCETRIS is an antibody-drug conjugate directed to CD30, which is expressed in classical Hodgkin lymphoma and systemic ALCL, a type of T-cell lymphoma.
Tags: from
data
seattle
survival
Sites : [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] next »